Opioid Use Disorder Market 2027 By Drug Type and Geography | The Insight Partners

Opioid Use Disorder Market to 2027 - Global Analysis and Forecasts By Drug Type (Buprenorphine, Methadone, Naltrexone) and Geography

Report Code: TIPRE00006732 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Opioid Use Disorder (OUD) is a type of chronic disorder that is associated with repeated self-administration of opioids, prolonged self-administration of opioid drugs and compulsive use of opioid drugs. Patients addicted to medical opioids, and the patients addicted to non-medical opioids, both suffers through the opioid use disorder. Opioid use disorder causes due to genetic and environmental factors.


MARKET DYNAMICS

The Opioid Use Disorder market is anticipated to grow in the forecast period owing to driving factors such as rising incidence of opioid use disorder, government policies to control the opioid use disorder, and rising investments by private pharmaceutical players.

MARKET SCOPE

The "Global Opioid Use Disorder Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Opioid Use Disorder market with detailed market segmentation by drug type, and geography. The global Opioid Use Disorder market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Opioid Use Disorder market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Opioid Use Disorder market is segmented on the basis of drug type. Based on drug type the market is segmented into Buprenorphine, Methadone, and Naltrexone. Buprenorphine segment is further sub segmented into Bunavail, Sublocade, Suboxone, Zubsolv, and Others.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Opioid Use Disorder market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Opioid Use Disorder market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Opioid Use Disorder market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Opioid Use Disorder market in these regions.


MARKET PLAYERS


The reports cover key developments in the Opioid Use Disorder market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Opioid Use Disorder market are anticipated to lucrative growth opportunities in the future with the rising demand for Opioid Use Disorder market in the global market. Below mentioned is the list of few companies engaged in the Opioid Use Disorder market.

The report also includes the profiles of key Opioid Use Disorder market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Indivior
  •  Alkermes
  •  Titan Pharmaceuticals
  •  Hikma Pharmaceuticals
  •  Teva Pharmaceuticals
  •  MediciNova
  •  Orexo
  •  Camurus
  •  Omeros
  •  Amygalda Neurosciences
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Opioid Use Disorder Market - By Drug Type
1.3.2 Opioid Use Disorder Market - By Region
1.3.2.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. OPIOID USE DISORDER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. OPIOID USE DISORDER MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. OPIOID USE DISORDER MARKET - GLOBAL MARKET ANALYSIS

6.1. OPIOID USE DISORDER - GLOBAL MARKET OVERVIEW
6.2. OPIOID USE DISORDER - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. OPIOID USE DISORDER MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE

7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. BUPRENORPHINE
7.3.1. Overview
7.3.2. Buprenorphine Market Forecast and Analysis
7.3.3. Bunavail Market
7.3.3.1. Overview
7.3.3.2. Bunavail Market Forecast and Analysis
7.3.4. Sublocade Market
7.3.4.1. Overview
7.3.4.2. Sublocade Market Forecast and Analysis
7.3.5. Suboxone Market
7.3.5.1. Overview
7.3.5.2. Suboxone Market Forecast and Analysis
7.3.6. Zubsolv Market
7.3.6.1. Overview
7.3.6.2. Zubsolv Market Forecast and Analysis
7.3.7. Others Market
7.3.7.1. Overview
7.3.7.2. Others Market Forecast and Analysis
7.4. METHADONE
7.4.1. Overview
7.4.2. Methadone Market Forecast and Analysis
7.5. NALTREXONE
7.5.1. Overview
7.5.2. Naltrexone Market Forecast and Analysis

8. OPIOID USE DISORDER MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
8.1.1 North America Opioid Use Disorder Market Overview
8.1.2 North America Opioid Use Disorder Market Forecasts and Analysis
8.1.3 North America Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.1.4 North America Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.1.4.1 United States Opioid Use Disorder Market
8.1.4.1.1 United States Opioid Use Disorder Market by Drug Type
8.1.4.2 Canada Opioid Use Disorder Market
8.1.4.2.1 Canada Opioid Use Disorder Market by Drug Type
8.1.4.3 Mexico Opioid Use Disorder Market
8.1.4.3.1 Mexico Opioid Use Disorder Market by Drug Type
8.2. EUROPE
8.2.1 Europe Opioid Use Disorder Market Overview
8.2.2 Europe Opioid Use Disorder Market Forecasts and Analysis
8.2.3 Europe Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.2.4 Europe Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Opioid Use Disorder Market
8.2.4.1.1 Germany Opioid Use Disorder Market by Drug Type
8.2.4.2 France Opioid Use Disorder Market
8.2.4.2.1 France Opioid Use Disorder Market by Drug Type
8.2.4.3 Italy Opioid Use Disorder Market
8.2.4.3.1 Italy Opioid Use Disorder Market by Drug Type
8.2.4.4 Spain Opioid Use Disorder Market
8.2.4.4.1 Spain Opioid Use Disorder Market by Drug Type
8.2.4.5 United Kingdom Opioid Use Disorder Market
8.2.4.5.1 United Kingdom Opioid Use Disorder Market by Drug Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Opioid Use Disorder Market Overview
8.3.2 Asia-Pacific Opioid Use Disorder Market Forecasts and Analysis
8.3.3 Asia-Pacific Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.3.4 Asia-Pacific Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Opioid Use Disorder Market
8.3.4.1.1 Australia Opioid Use Disorder Market by Drug Type
8.3.4.2 China Opioid Use Disorder Market
8.3.4.2.1 China Opioid Use Disorder Market by Drug Type
8.3.4.3 India Opioid Use Disorder Market
8.3.4.3.1 India Opioid Use Disorder Market by Drug Type
8.3.4.4 Japan Opioid Use Disorder Market
8.3.4.4.1 Japan Opioid Use Disorder Market by Drug Type
8.3.4.5 South Korea Opioid Use Disorder Market
8.3.4.5.1 South Korea Opioid Use Disorder Market by Drug Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Opioid Use Disorder Market Overview
8.4.2 Middle East and Africa Opioid Use Disorder Market Forecasts and Analysis
8.4.3 Middle East and Africa Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.4.4 Middle East and Africa Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Opioid Use Disorder Market
8.4.4.1.1 South Africa Opioid Use Disorder Market by Drug Type
8.4.4.2 Saudi Arabia Opioid Use Disorder Market
8.4.4.2.1 Saudi Arabia Opioid Use Disorder Market by Drug Type
8.4.4.3 U.A.E Opioid Use Disorder Market
8.4.4.3.1 U.A.E Opioid Use Disorder Market by Drug Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Opioid Use Disorder Market Overview
8.5.2 South and Central America Opioid Use Disorder Market Forecasts and Analysis
8.5.3 South and Central America Opioid Use Disorder Market Forecasts and Analysis - By Drug Type
8.5.4 South and Central America Opioid Use Disorder Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Opioid Use Disorder Market
8.5.4.1.1 Brazil Opioid Use Disorder Market by Drug Type
8.5.4.2 Argentina Opioid Use Disorder Market
8.5.4.2.1 Argentina Opioid Use Disorder Market by Drug Type

9. INDUSTRY LANDSCAPE

9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

10. OPIOID USE DISORDER MARKET, KEY COMPANY PROFILES

10.1. INDIVIOR
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. ALKERMES
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. TITAN PHARMACEUTICALS
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. HIKMA PHARMACEUTICALS
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. TEVA PHARMACEUTICALS
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. MEDICINOVA
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. OREXO
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. CAMURUS
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. OMEROS
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. AMYGALDA NEUROSCIENCES
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments

11. APPENDIX

11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Indivior
2. Alkermes
3. Titan Pharmaceuticals
4. Hikma Pharmaceuticals
5. Teva Pharmaceuticals
6. MediciNova
7. Orexo
8. Camurus
9. Omeros
10. Amygalda Neurosciences